Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01780935
What this trial is testing

Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 671
Testing effectiveness (Phase 2)Active Not RecruitingNCT06087458
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationGeographic AtrophyNon-neovascular AMD+1 more
Perceive Biotherapeutics, Inc. 60
Early research (Phase 1)Study completedNCT02033668
What this trial is testing

Pharmacokinetic (PK) Study of GSK933776 in Healthy Volunteers

Who this might be right for
Atrophy, Geographic
GlaxoSmithKline 36
Not applicableNot Yet RecruitingNCT07605468
What this trial is testing

Feasibility Study of a Remote Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension

Who this might be right for
Age-Related Macular Degeneration
Stanford University 32
Not applicableLooking for participantsNCT05454124
What this trial is testing

Factors in Learning And Plasticity: Macular Degeneration

Who this might be right for
Central Visual ImpairmentMacular Degeneration
University of Alabama at Birmingham 60
Post-approval studies (Phase 4)WithdrawnNCT02634970
What this trial is testing

CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab

Who this might be right for
Wet Age-related Macular Degeneration (Wet AMD)
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT03033108
What this trial is testing

Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease

Who this might be right for
Stargardt DiseaseMacular Atrophy
Kubota Vision Inc. 23
Post-approval studies (Phase 4)Study completedNCT01958918
What this trial is testing

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 712
Large-scale testing (Phase 3)Ended earlyNCT02980874
What this trial is testing

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Clearside Biomedical, Inc. 460
Not applicableLooking for participantsNCT07640997
What this trial is testing

Real-world Study of Aflibercept 8 mg in nAMD

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Peking University People's Hospital 300
Testing effectiveness (Phase 2)Study completedNCT03423823
What this trial is testing

Ziv-aflibercept Efficacy in Better Regulating AMD

Who this might be right for
Wet Macular DegenerationWet Age-related Macular Degeneration
Kapil Kapoor 62
Not applicableStudy completedNCT01833325
What this trial is testing

Proton Radiation Therapy for Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
University of Florida 9
Testing effectiveness (Phase 2)WithdrawnNCT00846625
What this trial is testing

Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids

Who this might be right for
Macular EdemaUveitis
University of Utah
Not applicableActive Not RecruitingNCT05300724
What this trial is testing

An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Genentech, Inc. 400
Not applicableActive Not RecruitingNCT05690880
What this trial is testing

ForeseeHome NRich Registry

Who this might be right for
Age-Related Macular Degeneration
Notal Vision Inc. 20,000
Not applicableLooking for participantsNCT05706896
What this trial is testing

Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma

Who this might be right for
Dry Age-related Macular Degeneration
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 36
Large-scale testing (Phase 3)WithdrawnNCT00930189
What this trial is testing

Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization

Who this might be right for
Subfoveal Choroidal Neovascularization
Asociación para Evitar la Ceguera en México
Large-scale testing (Phase 3)UnknownNCT05727397
What this trial is testing

Efficacy and Safety of RC28-E Versus Aflibercept

Who this might be right for
Wet Age-related Macular Degeneration
RemeGen Co., Ltd. 432
Not applicableActive Not RecruitingNCT04420923
What this trial is testing

Optimizing the Treatment Strategy for Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
St. Olavs Hospital 250
Testing effectiveness (Phase 2)Study completedNCT05062486
What this trial is testing

Evaluate the Safety and Efficacy of RQC for AMD

Who this might be right for
Age-related Macular Degeneration
Paul A Knepper, MD PhD 55
Next Page